The equities market, along with stock exchange traded funds, sprinted through July, reaching new record highs, after the quick correction in June.

The Dow Jones Industrial Average was 4.3% higher over July. Meanwhile, the Nasdaq Composite increased 6.3% and the S&P 500 rose 5.1%.

The top non-leveraged ETFs over July include the Guggenheim Solar ETF (NYSEArca: TAN) up 19.8%, PureFunds ISE Junior Silver ETF (NYSEArca: SILJ) up 18.0% and the SPDR S&P Biotech ETF (NYSEArca: XBI) up 15.9%.

The solar sector has been outshining the broader markets for most of the year as the industry capitalizes on the greater push for alternative energy sources. [Solar ETFs Shine As China Expands Capacity]

After the swift exodus from precious metals, the lower prices have enticed investors back into silver. Additionally, the downtrodden miner industry is finally catching a break with investors pouncing on undervalued silver producers. [Obscure Silver Miners ETF Up 10% This Month]

Biotech stocks are surging on innovative drug applications filed with the FDA, robust earnings and positive drug trials, according to Minyanville.

The worst performing non-leveraged ETFs for the month include the ProShares VIX Short-Term Futures ETF (NYSEArca: VIXY) down 25.9%, ProShares VIX Mid-Term Futures ETF (NYSEArca: VIXM) down 14.9% and Market Vectors Indonesia Small-Cap ETF (NYSEArca: IDXJ) down 11.1%.